Correlations of IL-23R gene polymorphism with clinicopathological characteristics and prognosis of hepatocellular carcinoma patients after interventional therapy.

[1]  A. Settin,et al.  Genetic polymorphisms of IL-23R (rs7517847) and LEP (rs7799039) among Egyptian patients with hepatocellular carcinoma , 2017, Archives of physiology and biochemistry.

[2]  Samira Mohammadi-Yeganeh,et al.  Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[3]  Lianghai Wang,et al.  A Genetic Variant in miRNA-219-1 Is Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Kazakhs , 2015, Disease markers.

[4]  Xiao-ping Chen,et al.  The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. , 2015, International journal of surgery.

[5]  Yingying Zhao,et al.  MicroRNAs Contribute to Hepatocellular Carcinoma. , 2015, Mini reviews in medicinal chemistry.

[6]  Hong Wang,et al.  Incidence and Risk Factors for Hepatocellular Carcinoma in Primary Biliary Cirrhosis , 2015, Clinical Reviews in Allergy & Immunology.

[7]  S. Shalaby,et al.  Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma. , 2015, Cellular immunology.

[8]  B. Yalçın,et al.  Association of interleukin‐23 receptor gene polymorphism with Behçet disease , 2014, Clinical and experimental dermatology.

[9]  Y. Nie,et al.  ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma , 2014, Oncogene.

[10]  M. Oukka,et al.  IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism , 2013, Mucosal Immunology.

[11]  M. Wakui.  [Analysis of single nucleotide polymorphisms (SNPs)]. , 2013, Rinsho byori. The Japanese journal of clinical pathology.

[12]  Shan Li,et al.  Correlation between interleukin‑23 receptor gene polymorphisms and risk of hepatitis B virus infection in patients. , 2013, Molecular medicine reports.

[13]  S. Thorgeirsson,et al.  Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. , 2013, Gastroenterology.

[14]  K. O'Byrne,et al.  IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer , 2013, Front. Oncol..

[15]  C. Carlson,et al.  Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer. , 2012, Cancer epidemiology.

[16]  Hongbing Shen,et al.  IL-23R polymorphisms, HBV infection, and risk of hepatocellular carcinoma in a high-risk Chinese population , 2012, Journal of Gastroenterology.

[17]  R. Shi,et al.  [Association of interleukin-23 receptor gene polymorphisms with susceptibility and phenotypes of inflammatory bowel diseases in Jiangsu Han population]. , 2011, Zhonghua nei ke za zhi.

[18]  Hongbing Shen,et al.  IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high‐risk Chinese population , 2011, International journal of cancer.

[19]  Hongbing Shen,et al.  A nonsynonymous polymorphism in IL23R gene is associated with risk of gastric cancer in a Chinese population , 2010, Molecular carcinogenesis.

[20]  C. Pulitano,et al.  Liver Resection with Portal Vein Thrombectomy for Hepatocellular Carcinoma With Vascular Invasion , 2009, Annals of Surgical Oncology.

[21]  L. Sarna,et al.  Symptom management in hepatocellular carcinoma. , 2008, Clinical journal of oncology nursing.

[22]  J. Bruix,et al.  Molecular targeted therapies in hepatocellular carcinoma , 2008, Hepatology.

[23]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[24]  Zhao-You Tang,et al.  Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Iwona Wrobel,et al.  IL‐23 receptor (IL‐23R) gene protects against pediatric Crohn's disease , 2007, Inflammatory bowel diseases.

[26]  A. Anichini,et al.  T cell infiltration and prognosis in HCC patients. , 2006, Journal of hepatology.

[27]  J. Marrero,et al.  Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. , 2005, Journal of hepatology.

[28]  F. Marotta,et al.  The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect. , 2004, La Clinica terapeutica.

[29]  Lisa A Desjardins.  Hepatocellular carcinoma. , 2002, Clinical journal of oncology nursing.

[30]  C. Bréchot,et al.  Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). , 2000, Seminars in cancer biology.

[31]  H. Adami,et al.  Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma , 2000, International journal of cancer.